Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AbCellera

AbCellera
2012 FOUNDED
PRIVATE STATUS
71-80 EMPLOYEES
Series A LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of monoclonal antibodies designed to accelerate the discovery and development of next-generation antibody therapies. The company's platform partners with pharmaceutical and biotech for therapeutic antibody discovery and immune profiling, increasing the speed and efficiency of antibody discovery from natural immune responses of immunized animals and human patients, enabling new avenues for human immune profiling and infectious disease research, with the potential to accelerate the development of urgently needed diagnostic tests and vaccines.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 2215 Yukon Street
  • Vancouver, British Columbia V5Y 0A1
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AbCellera’s full profile, request a free trial.

AbCellera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 27-Sep-2018 $10M 0000 Completed Generating Revenue
5. Grant 25-Jan-2018 Completed Generating Revenue
4. Grant 19-Jan-2017 Completed Generating Revenue
3. Grant 26-Jun-2015 00000 Completed Startup
2. Seed Round 09-Aug-2014 Completed Startup
1. Grant 27-Sep-2013 $62K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AbCellera Competitors (53)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fate Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed La Jolla, CA 00000 00000000000 00000
00000000 000000000 Formerly VC-backed Cambridge, MA 000 0000 000000000 0000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000 000000000000 Venture Capital-Backed Basel, Switzerland 00.000 00000000000 00.000
To view this company’s complete list of competitors, request access »

AbCellera Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 01-Aug-2018 000000000000000000 Other Pharmaceuticals and Biotechnology 0000 000000 00.0
To view this company’s complete investment and acquisition history, request access »

AbCellera Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Data Collective Venture Capital Minority 000 0000 000000 0
Brain Canada Government 000 0000 000000 0
CQDM Government 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Western Economic Diversification Canada Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

AbCellera Executive Team (9)

Name Title Board
Seat
Contact
Info
Carl Hansen Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Andrew Booth Chief Financial Officer
Kevin Heyries Ph.D Executive
Kathleen Lisaingo Ph.D Co-Founder and Group Leader
Veronique Lecault Co-Founder, Executive of Corporate Development & Board Member

2 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

AbCellera Board Members (6)

Name Representing Role Since Contact
Info
Carl Hansen Ph.D AbCellera Co-Founder, President, Chief Executive Officer & Board Member 000 0000
John Hamer Ph.D Data Collective Board Member 000 0000
Michael Hayden Ph.D Self Board Member 000 0000
Veronique Lecault AbCellera Co-Founder, Executive of Corporate Development & Board Member 000 0000

2 Former Board Members

You’re viewing 4 of 6 board members. Get the full list »